Author

Bo-Yang Li

h-index 4 View on Semantic Scholar

We have 2 of 17 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Post-translational modification-governed immune states in cancer immunity: Biomarker implications for checkpoint competence, tumor visibility and immunotherapy resistance (Review)

By organizing PTM biology around measurable state variables rather than modification class alone, the present review provides a phase-aware translational framework for candidate biomarker discovery, fit-for-purpose validation, constraint-guided stratification, and therapeutic prioritization in cancer immunotherapy.

Jing-Hao Pan, Bo-Yang Li, Ruo-Nan Lin et al. · International Journal of Onc... · 1 citation

Review Sep 2026

Metabolic and epigenetic plasticity of tumor-associated macrophages shapes immunosuppressive outputs and immune checkpoint response.

Immune checkpoint blockade (ICB) has transformed cancer therapy, but durable responses are frequently limited by tumor microenvironment-driven resistance. Tumor-associated macrophages (TAMs) are central mediators of this process because they sense metabolic stress and convert it into immunosuppressive programs that res...

Jing-Hao Pan, Bo-Yang Li, Lucy Yue Lau et al. · Biochimica et biophysica act... · 0 citations